Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to $175.3 million.

  • Select Medical Holdings' Cash from Operations fell 312.87% to $175.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $407.6 million, marking a year-over-year decrease of 2873.01%. This contributed to the annual value of $517.9 million for FY2024, which is 1102.88% down from last year.
  • Per Select Medical Holdings' latest filing, its Cash from Operations stood at $175.3 million for Q3 2025, which was down 312.87% from $110.3 million recorded in Q2 2025.
  • In the past 5 years, Select Medical Holdings' Cash from Operations registered a high of $278.2 million during Q2 2024, and its lowest value of -$66.7 million during Q1 2024.
  • For the 5-year period, Select Medical Holdings' Cash from Operations averaged around $108.8 million, with its median value being $116.3 million (2023).
  • Per our database at Business Quant, Select Medical Holdings' Cash from Operations soared by 133050.06% in 2023 and then plummeted by 22964.42% in 2024.
  • Quarter analysis of 5 years shows Select Medical Holdings' Cash from Operations stood at -$60.8 million in 2021, then skyrocketed by 120.65% to $12.5 million in 2022, then skyrocketed by 1330.5% to $179.4 million in 2023, then crashed by 30.1% to $125.4 million in 2024, then soared by 39.76% to $175.3 million in 2025.
  • Its Cash from Operations was $175.3 million in Q3 2025, compared to $110.3 million in Q2 2025 and -$3.5 million in Q1 2025.